CEO Karsten Lindhardt will present the groundbreaking BIONDD™ technology at 4.30pm with the title “Oral Delivery of Biologics with Bioavailability Similar to […]
Interview Karsten Lindhardt: “We are uniquely positioned to succeed” (verve.vc) The use of injections in treatments is widespread, but their use can […]
On February 27th 2024, Karsten Lindhardt CEO and founder of Biograil had the pleasure of presenting the BIONDD™ technology to an exclusive audience at […]